Optimizing Pharma Engagement with Causal AI-powered AI Agents for Precision Impact

This session explores how Causal AI transforms pharma engagement by moving beyond traditional attribution models to measure true causal impact. It highlights how Syneos, in collaboration with CausaLens, applies causal inference to drive precision engagement in pharma and explores the future of continuous optimization powered by AI. The discussion will also cover how AI agents automate resource allocation and next-best-action recommendations, shifting from retrospective analysis to real-time decision-making.

• 
  Bharathi Ramachandran Director, Data Science, Syneos Health
• 
  Adam Cahill General Manager, Kinetic , Syneos Health